Skip to content
healthcare.dev

TEMOZOLOMIDE

NDC 16571-817, temozolomide, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-817
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206309
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-817 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE20 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
16571-817-021657108170220 CAPSULE in 1 BOTTLE (16571-817-02)
16571-817-411657108174114 CAPSULE in 1 BOTTLE (16571-817-41)
16571-817-51165710817515 CAPSULE in 1 BOTTLE (16571-817-51)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70996a9d-4a4f-4ed1-ab07-130486aa14ab
  • NADAC price for package 16571081741

    GET /v1/drugs/nadac/16571081741
  • NADAC price for package 16571081751

    GET /v1/drugs/nadac/16571081751

Use it

Look up 16571-817 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-817 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-817. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.